Agilis Robotics announces successful in vivo bladder-tumour test
Agilis Robotics announced that its flexible endoscopic robot had completed an in vivo artificial bladder-tumour resection test.
Evidence notes
- The test used robotic arms less than 2.8 millimetres in diameter with conventional urology telescopes and sheaths.
- The instruments clamped and cut the artificial tumour tissue and removed the tumour in one piece.
- Agilis positioned the result as a step from prototype and cadaver work toward a first-in-human study.
Company context
Agilis Robotics develops miniature flexible robotic instruments for endoluminal surgery. The platform is designed to navigate natural anatomical pathways and give surgeons dexterous control in procedures where conventional rigid instruments have limited reach.